U.S.-based investment firm Vanguard Group Inc. has bought a stake in Canadian speciality pharmaceutical company Bausch Health Companies Inc.

Valued at approximately $223.2 million, Vanguard Group acquired 8.7 million shares of Bausch Health Companies’ stock.

Bausch Health Companies has a market capitalization of $6.46 billion.

During the last quarter, Bausch Health Companies booked $2.14 billion in revenue.